Main content
Written by Sean Moshrefi, PharmD, MS · Medically reviewed by Shant Pezeshkian, DO, MPH · Updated June 27, 2026

Do You Need a Glucose Monitor If You're Not Diabetic?

Over-the-counter glucose monitors like Stelo and Lingo are marketed to healthy people for metabolic 'optimization.' What the evidence actually shows — and who really benefits.

SM

Sean Moshrefi, PharmD, MS

9 min read · Reviewed by Shant Pezeshkian, DO, MPH

Key takeaways

  • Continuous glucose monitors (CGMs) are now available over the counter — Dexcom's Stelo and Abbott's Lingo — and heavily marketed to people without diabetes as metabolic optimization tools.
  • The evidence for healthy, normoglycemic people is weak. A 2026 systematic review found CGMs improved glucose control in people with prediabetes, but showed no appreciable glycemic benefit in healthy normoglycemic individuals.
  • Glucose 'spikes' after meals are normal physiology, not a disease. Studies of healthy people wearing CGMs show that everyone has glucose rises and falls throughout the day — seeing one does not mean something is wrong.
  • Glucose responses are highly individual. The same food produces different responses in different people based on diet, lifestyle, and biology, which limits how much you can generalize from a single reading.
  • CGMs can be a useful short-term educational and behavior-change tool — especially in prediabetes — but they are not a proven longevity intervention, and there's no evidence they improve hard health outcomes in healthy people.
  • Real downsides exist: cost, measurement lag and error, and the risk of anxiety or over-restriction from chasing normal glucose fluctuations.

A few years ago, continuous glucose monitors were medical devices, prescribed almost exclusively to people with diabetes who needed to track their blood sugar to dose insulin safely. Today you can buy one off the shelf, no prescription required, and an entire wellness industry is encouraging healthy people to wear them to “optimize” their metabolism, hack their diet, and chase flat glucose curves.

So the practical question a lot of people are now asking is reasonable: if you don’t have diabetes, is a glucose monitor actually worth wearing? The short answer is that for most healthy people it’s optional at best — useful as a short-term learning tool, occasionally helpful in prediabetes, and easy to misuse in ways that create anxiety rather than insight. Here’s the longer version.


What a CGM Actually Measures

A continuous glucose monitor is a small sensor, usually worn on the back of the upper arm, with a tiny filament that sits just under the skin. It measures glucose in the interstitial fluid (the fluid between cells) and sends a reading to your phone every few minutes, for roughly 10 to 15 days per sensor before it’s replaced.

Two details matter for interpretation. First, it’s measuring interstitial glucose, not blood directly, so there’s a lag of several minutes and a margin of error — the number on your phone is a close estimate, not a lab-perfect blood value. Second, the consumer versions made for people without diabetes are designed to show trends and patterns, not to deliver urgent low-glucose alarms, because they’re intended for people who aren’t at risk of dangerous lows.

In 2024, the FDA cleared the first over-the-counter CGMs for people without diabetes — Dexcom’s Stelo and Abbott’s Lingo — which is what moved these devices from the pharmacy counter into the general wellness market.


What the Evidence Shows in People Without Diabetes

This is where the marketing and the data diverge.

A 2026 systematic review and meta-analysis pulled together 23 studies of CGMCGM (continuous glucose monitor) A small wearable sensor that measures glucose in the fluid just under the skin every few minutes and sends readings to your phone. Designed to show trends and patterns rather than single blood-sugar snapshots. use in non-diabetic people — over a thousand participants across 11 countries. The findings were mixed and worth stating precisely. CGM use modestly improved average blood glucose compared with control conditions and was associated with better adherence to lifestyle changes and specific dietary modifications. But the benefit was concentrated in people with prediabetes. In healthy, normoglycemic participants — people whose blood sugar was already normal — there was no appreciable glycemic benefit. The review also found CGMs did not, on their own, achieve weight-management goals without an accompanying behavior-change program.

The authors’ conclusion is a fair summary: a CGM is best understood as a “precision biofeedback tool” that works inside a structured lifestyle program — not a standalone intervention, and not something with demonstrated benefit for already-healthy people. Critically, no study has shown that wearing a CGM improves hard health outcomes — things like heart disease or longevity — in people without diabetes.


”Spikes” Are Normal — Don’t Pathologize Physiology

Much of the anxiety CGMs generate comes from a basic misunderstanding: the belief that any rise in blood sugar after eating is harmful. It isn’t. A post-meal glucose rise is normal, expected physiology.

When researchers put CGMs on healthy, non-diabetic people and simply observed, they found that everyone’s glucose moves up and down throughout the day, with rises after meals and returns to baseline afterward. Healthy participants spent the large majority of the day in a normal range, but excursions — including spikes after carbohydrate-rich meals — were a routine part of normal metabolism, not a warning sign.

This is the crux of the problem for a metabolically healthy person wearing a CGM: they will see spikes, because spikes are normal, and without context they may interpret ordinary physiology as a problem to be eliminated. Flattening every curve is not a validated health goal, and pursuing it can tip into needless food fear.


Who Might Actually Benefit

The case for a CGM in a non-diabetic person is strongest in a few specific situations:

People with prediabetes or a strong family history of type 2 diabetes, where the evidence shows real glycemic benefit and where early behavior change genuinely matters. People who want a short-term, structured experiment — two to four weeks of wearing a sensor to learn how their own meals, exercise, sleep, and stress affect their glucose, then using that knowledge to make durable changes. And people who are simply curious and will treat the data as education rather than a source of stress.

The common thread is that the value comes from acting on what you learn, within a defined window, not from wearing a sensor indefinitely in pursuit of a perfectly flat line.


Who Probably Doesn’t Need One

For a metabolically healthy person with normal blood sugar, a CGM is unlikely to deliver meaningful health benefit, and it carries some real downsides. There’s the cost of an ongoing sensor subscription. There’s the measurement lag and error that can make readings look more alarming or erratic than reality. And there’s the psychological risk that deserves more attention than it gets: for people prone to health anxiety or disordered eating, continuous data on a number they’re told to minimize can drive over-restriction and stress over normal fluctuations.

If your goal is genuine metabolic health, the higher-yield moves are well established and don’t require a wearable: diet quality, regular exercise including resistance training, adequate sleep, and standard blood work. If you want to know your actual metabolic risk, a few lab values — fasting glucose, HbA1cHbA1c (hemoglobin A1c) A blood test that shows your average blood sugar over the past ~3 months., and an insulin-resistance estimate like the one we cover in our HOMA-IR article — tell you more about your long-term risk than a flurry of CGM spikes, and our guide to lab testing covers how to get them.


Where This Leaves Us

The over-the-counter CGM is a genuinely impressive piece of technology that has been handed a marketing story bigger than its evidence. For people with diabetes and, to a lesser degree, prediabetes, it’s a legitimately useful tool. For the healthy person hoping it will unlock a new tier of optimization, the honest answer is that the data aren’t there — and that the device can just as easily generate anxiety about normal physiology as it can generate insight.

Used deliberately, for a defined period, with a clear understanding that post-meal rises are normal, a CGM can teach you something useful about your own body. Worn indefinitely in pursuit of a flat line you were never meant to have, it’s more likely to cost you money and peace of mind than to add years to your life.


A note on context: This article is about people without diabetes using CGMs for wellness. If you have diabetes or take glucose-lowering medication, CGMs are a different and often genuinely valuable story, and your use of one should be guided by your care team rather than this general overview.

Frequently asked questions (FAQ)

Are glucose spikes after meals bad for you?

Not in a healthy person. A rise in blood sugar after eating is normal physiology. Studies of healthy, non-diabetic people wearing glucose monitors show everyone's glucose rises and falls throughout the day, so seeing a spike does not mean something is wrong.

Is a continuous glucose monitor worth it if I'm not diabetic?

For most healthy people, it's optional. The measurable benefit is concentrated in people with prediabetes; in healthy, normoglycemic individuals, a 2026 review found no appreciable glycemic benefit and there's no evidence CGMs improve long-term health outcomes. They can still be a useful short-term tool for learning your own patterns.

Do glucose monitors help with weight loss?

Not on their own. The evidence shows CGMs do not achieve weight-management goals without an accompanying structured behavior-change program. They're best thought of as a biofeedback tool inside a broader plan, not a weight-loss device.

How accurate are over-the-counter glucose monitors like Stelo and Lingo?

They measure glucose in the fluid under the skin rather than blood directly, so there's a lag of several minutes and a margin of error. The number on your phone is a close estimate of your blood glucose, not a lab-perfect value, and the consumer versions are designed to show trends rather than deliver urgent alerts.

Who actually benefits from wearing a CGM?

People with diabetes benefit most and should be guided by their care team. There's also real benefit in prediabetes. Beyond that, the best use for a healthy person is a defined short experiment — a few weeks to learn how your meals, sleep, stress, and exercise affect your glucose — followed by acting on what you learned.

The pharmacist's bottom line

For most people without diabetes, a continuous glucose monitor is not a necessity — it's an optional gadget that can be genuinely useful in the right hands and a source of needless worry in the wrong ones. The honest read of the evidence is narrow but clear: CGMs help people with prediabetes tighten up their glucose and stick to behavior changes, and they can be a powerful short-term teaching tool for seeing how your own meals, sleep, stress, and movement affect your blood sugar. What they have not been shown to do is improve hard health outcomes in healthy, normoglycemic people, or to drive weight loss on their own. And there's a real failure mode: a metabolically healthy person watching normal post-meal spikes can talk themselves into anxiety or unnecessary food restriction over physiology that was never a problem. If you have prediabetes, a strong family history of diabetes, or you simply want a two-week, structured experiment to learn your own patterns and then act on them, a CGM can be worth it. If you're metabolically healthy and chasing 'optimization,' your money and attention are better spent on the fundamentals — diet quality, exercise, sleep, and standard lab work — that actually move the needle.

Sources (3)
  1. 1. Liao X, Li Y, Tang S, et al. Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis. European Journal of Medical Research. 2026;31.
  2. 2. Shah VN, DuBose SN, Li Z, et al. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. Journal of Clinical Endocrinology & Metabolism. 2019;104(10):4356–4364.
  3. 3. Bermingham KM, Smith HA, Duncan EL, et al. Associations of continuous glucose monitor derived time in range and glycaemic variability with diet, lifestyle and demographics. Nature Communications. 2026;17(1):4496.

About the author

SM

Sean Moshrefi, PharmD, MS

Clinical Pharmacist

View full profile →

Was this article helpful?

Enjoyed this one?

Get more breakdowns like this, straight to your inbox

Written by PharmDs, free, no spam — new articles land in your inbox before they hit the feed.

Free. No spam. Unsubscribe anytime.

Order your own labs

Affiliate links. We may earn a commission at no cost to you.